Novus Pathologies Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 11-12-2024
- Paid Up Capital ₹ 0.10 M
as on 11-12-2024
- Company Age 8 Year, 19 Days
- Last Filing with ROC 31 Mar 2024
- Revenue -33.04%
(FY 2020)
- Profit -99.61%
(FY 2020)
- Ebitda -38.06%
(FY 2020)
- Net Worth -230.53%
(FY 2020)
- Total Assets -26.69%
(FY 2020)
About Novus Pathologies
The Company is engaged in the Business Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Vikas Kothiyal, Narendrakumar Bhatt, Kashmira Bhatt, and One other member serve as directors at the Company.
- CIN/LLPIN
U74999UR2016PTC007438
- Company No.
007438
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Dec 2016
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Uttarakhand
Industry
Company Details
- Location
Dehradun, Uttarakhand, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Novus Pathologies?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vikas Kothiyal  | Director | 06-Dec-2016 | Current |
| Narendrakumar Bhatt | Director | 28-Mar-2024 | Current |
| Kashmira Bhatt | Director | 28-Mar-2024 | Current |
| Manoj Mishra | Director | 29-Mar-2024 | Current |
Financial Performance of Novus Pathologies.
Novus Pathologies Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 33.04% decrease. The company also saw a substantial fall in profitability, with a 99.61% decrease in profit. The company's net worth observed a substantial decline by a decrease of 230.53%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Novus Pathologies?
Unlock access to Novus Pathologies's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Medvita Healthtech Private LimitedActive 1 year 5 monthsNarendrakumar Bhatt and Kashmira Bhatt are mutual person
- Krsnaa Diagnostics Global Health Care Private LimitedActive 10 months 23 days
Kashmira Bhatt is a mutual person
- Shreeanagha Kr Foundation And Research InstituteActive 2 months 20 days
Kashmira Bhatt is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Novus Pathologies?
Unlock and access historical data on people associated with Novus Pathologies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Novus Pathologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Novus Pathologies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
